Portugal’s Diabetes Rate Hits Record High as Screening Lags

Portugal’s struggle with diabetes is no longer a worrying forecast; it is a daily reality with economic, social and human consequences visible from Braga’s polyclinics to Faro’s pharmacies. The latest figures confirm that more people are living with the condition than ever before, that nearly half remain unaware of it, and that one of the most devastating complications—lower-limb amputation—refuses to decline. Add a health-care system still wrestling with fragmented data and rising drug bills, and the picture becomes impossible to ignore.

The Silent Climb of a National Epidemic

The country has reached 14.2% prevalence, an indisputable historic high that translates into 88,476 new diagnoses recorded in Primary Care during 2024 alone, according to the Portuguese Society of Diabetology. That growth keeps the epidemic curve pointing upward even as Nationwide surveillance improves. More than 1.1 M members of the adult population are now officially counted, yet hotspots in urban centers show faster growth, and younger age groups have begun to appear on registries with troubling regularity.

Under the Radar: The Hidden 44 %

Roughly 44% undiagnosed means nearly another million cases in waiting. Many consult private clinics, but fragmented records and digital barriers prevent a full picture. The disease’s often subtle symptoms slip past routine check-ups, especially in patients with multiple risk factors. Portugal’s participation in MyHealth@EU promises cross-border connectivity, yet domestic interoperability still lags, delaying early screening that could change life trajectories.

Costs that Ripple through the Economy

The headline figure—a €1.8B price tag—already absorbs 5% of health spending and 0.6% of GDP. Rising antidiabetic drugs expenditure reshapes pharmacy shelves and ties up hospital beds with preventable complications. Productivity losses from work absenteeism and higher insurance premiums feed a looming future tax burden. Experts insist that only preventive budgeting can curb these runaway costs.

Amputations: A Decade of Stalemate

Despite medical advances, the nation still sees an amputations plateau. Where multidisciplinary foot clinics exist, notably those born from Norma 5/2011, outcomes improve, especially when specialised podologists join the team. Elsewhere, major surgery continues to steal quality of life from patients in rural districts with less access to care. Campaigns spotlight public awareness, but clinicians warn that ulcer prevention and early referral remain uneven.

Data Gaps and the Private Puzzle

Every epidemiologist points to the data vacuum separating public records from private charts. A stubborn private–public firewall—anchored in systems such as SClínico and Sorian—makes the November 2025 ministerial order on private primary care a double-edged sword. Without clinical dashboards and real-time alerts, authorities are left guessing. Bridging the gap will require better evidence-based planning, solid cybersecurity and clear patient consent protocols.

Can Policy Close the Gap?

Lawmakers cite the State Budget 2026 as proof of ambition: fresh telemedicine funds, wider access to insulin pumps and a 17.3 B health package aimed at the Serviço Nacional de Saúde. Still, the chronic care index remains static until digital monitoring and primary care reform translate money into healthier bodies. Public-health economists talk of sustainable financing tied to outcomes and stronger health equity through new social partnerships.

What Comes Next for Patients and Clinicians?

Experts call for nationwide lifestyle shifts that revive the Mediterranean diet, expand walkable cities and overhaul school canteens. Employers are urged to back workplace wellness, and innovators pitch AI decision support that flags warning signs in community pharmacies. Above all, family doctors say they need to hear patient voices earlier and more often if Portugal hopes to bend the curve over the next decade.